CRESCENT BIOPHARMA, INC.
Most recent annual filing: 2026-02-26
Pipeline (10 active programs)
CR-002
- Undisclosed indication
CR-003
SKB105- Undisclosed indication
Biotech Distilled coverage (1)
- 2026-05-11 Crescent Bio (CBIO) - Scientific Deep Dive for CR-001, CR-003, and Pipeline Products 🔒 Paid
Articles open on Substack. Some deep dives are subscriber-only.